Dapsone-Induced Peripheral Neuropathy
- 1 October 1977
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 34 (10) , 644-646
- https://doi.org/10.1001/archneur.1977.00500220078017
Abstract
• Peripheral neuropathy is a rare complication of dapsone therapy. This neuropathy appears primarily to be of the motor type, and recovery occurs on discontinuation of the drug therapy. The patient in this report developed a marked motor deficit as well as a selective marked loss of vibration sense shortly after the initiation of a relatively low dose of dapsone. Recovery was rapid on cessation of the therapy. This patient was found to be a slow acetylator of isoniazid, and therefore is probably a slow acetylator of dapsone. The possible mechanisms of the neurotoxicity of dapsone and the role of altered metabolism are discussed.This publication has 8 references indexed in Scilit:
- Dapsone-induced peripheral neuropathyArchives of Dermatology, 1976
- Dapsone-induced motor polyneuropathy. A complication of prolonged treatment of subcorneal pustular dermatosisArchives of Dermatology, 1976
- Dapsone-Induced Peripheral NeuropathyArchives of Neurology, 1972
- DAPSONE INDUCED PERIPHERAL NEUROPATHYBritish Journal of Dermatology, 1972
- The polymorphic acetylation of dapsone in manClinical Pharmacology & Therapeutics, 1971
- Sulfapyridine and Sulfone Type Drugs in DermatologyArchives of Dermatology, 1962
- Genetic Control of Isoniazid Metabolism in ManBMJ, 1960